Antiphospholipid syndrome and acute myocardial infarction: Treatment with thrombectomy and abciximab

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Antiphospholipid syndrome (APS) is an autoimmune coagulation disorder that manifests clinically as venous and arterial thrombosis, and may affect any tissue or organ. Coronary artery involvement, however, is very rare. Case reports in the literature describing patients with coronary acute syndrome and APS treated with coronary angioplasty show conflicting results. We report an adult male patient with APS who presented with an acute myocardial infarction. Given the high risk of thrombosis in these patients, he was treated percutaneously with thrombectomy and abciximab. We review the few cases of coronary angioplasty in patients with APS reported to date. To our knowledge, this is the first case in which acute myocardial infarction due to thrombotic coronary occlusion was treated with thrombectomy and abciximab without stenting the artery.

Cite

CITATION STYLE

APA

Martí, V., Seixo, F., Santaló, M., & Serra, A. (2014). Antiphospholipid syndrome and acute myocardial infarction: Treatment with thrombectomy and abciximab. Revista Portuguesa de Cardiologia, 33(7–8), 465.e1-465.e4. https://doi.org/10.1016/j.repc.2014.01.020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free